Mark C. Maberry

726 total citations
20 papers, 468 citations indexed

About

Mark C. Maberry is a scholar working on Pediatrics, Perinatology and Child Health, Epidemiology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Mark C. Maberry has authored 20 papers receiving a total of 468 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Pediatrics, Perinatology and Child Health, 9 papers in Epidemiology and 4 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Mark C. Maberry's work include Preterm Birth and Chorioamnionitis (4 papers), Epilepsy research and treatment (3 papers) and Pharmacological Effects and Toxicity Studies (3 papers). Mark C. Maberry is often cited by papers focused on Preterm Birth and Chorioamnionitis (4 papers), Epilepsy research and treatment (3 papers) and Pharmacological Effects and Toxicity Studies (3 papers). Mark C. Maberry collaborates with scholars based in United States, Belgium and Puerto Rico. Mark C. Maberry's co-authors include George D. Wendel, Fiker Zeray, Jeanne S. Sheffield, Pablo J. Sánchez, Donald D. McIntire, Fernando Moya, Mohan Mysore, Larry C. Gilstrap, Josefina Romaguera and Alfred Bernard and has published in prestigious journals such as Biochemical Journal, American Journal of Obstetrics and Gynecology and Obstetrics and Gynecology.

In The Last Decade

Mark C. Maberry

19 papers receiving 444 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mark C. Maberry United States 12 126 124 119 117 108 20 468
Arif Serhan Cevrioğlu Türkiye 11 42 0.3× 93 0.8× 70 0.6× 62 0.5× 70 0.6× 37 390
Ernest W. Lowe United States 7 114 0.9× 46 0.4× 76 0.6× 24 0.2× 42 0.4× 10 365
Sultan Kavuncuoğlu Türkiye 12 116 0.9× 77 0.6× 56 0.5× 29 0.2× 136 1.3× 53 402
Demet Toprak United States 13 61 0.5× 128 1.0× 127 1.1× 69 0.6× 84 0.8× 33 512
G. Marc Jackson United States 9 193 1.5× 49 0.4× 183 1.5× 19 0.2× 77 0.7× 17 471
O. M. Petrucco Australia 16 172 1.4× 106 0.9× 49 0.4× 44 0.4× 59 0.5× 45 744
Jacqueline M. Melville Australia 9 147 1.2× 88 0.7× 153 1.3× 24 0.2× 222 2.1× 13 502
Alberto Chiara Italy 14 188 1.5× 59 0.5× 93 0.8× 18 0.2× 167 1.5× 24 536
J G Bissenden United Kingdom 14 178 1.4× 71 0.6× 90 0.8× 16 0.1× 70 0.6× 31 473
Chitra Raghunandan India 15 211 1.7× 47 0.4× 95 0.8× 24 0.2× 34 0.3× 25 528

Countries citing papers authored by Mark C. Maberry

Since Specialization
Citations

This map shows the geographic impact of Mark C. Maberry's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark C. Maberry with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark C. Maberry more than expected).

Fields of papers citing papers by Mark C. Maberry

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark C. Maberry. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark C. Maberry. The network helps show where Mark C. Maberry may publish in the future.

Co-authorship network of co-authors of Mark C. Maberry

This figure shows the co-authorship network connecting the top 25 collaborators of Mark C. Maberry. A scholar is included among the top collaborators of Mark C. Maberry based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark C. Maberry. Mark C. Maberry is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sheffield, Jeanne S., Pablo J. Sánchez, Mark C. Maberry, et al.. (2002). Congenital syphilis after maternal treatment for syphilis during pregnancy. American Journal of Obstetrics and Gynecology. 186(3). 569–573. 107 indexed citations
2.
Moya, Fernando, Josefina Romaguera, Mohan Mysore, et al.. (1995). Fetal lung maturation in congenital diaphragmatic hernia. American Journal of Obstetrics and Gynecology. 173(5). 1401–1405. 73 indexed citations
3.
Kulharya, Anita S., Mark C. Maberry, Mary K. Kukolich, et al.. (1995). Interstitial deletions 4q21.1q25 and 4q25q27: Phenotypic variability and relation to Rieger anomaly. American Journal of Medical Genetics. 55(2). 165–170. 28 indexed citations
4.
Roberts, S. A., et al.. (1995). Obstetric clavicular fracture: The enigma of normal birth. Obstetrics and Gynecology. 86(6). 978–981. 23 indexed citations
5.
Little, Bertis B., et al.. (1994). Megadose carbamazepine during the period of neural tube closure. International Journal of Gynecology & Obstetrics. 45(3). 306–306. 15 indexed citations
6.
Twickler, Diane M., Jeffrey M. Perlman, & Mark C. Maberry. (1993). Congenital Cytomegalovirus Infection Presenting as Cerebral Ventriculomegaly on Antenatal Sonography. American Journal of Perinatology. 10(5). 404–406. 20 indexed citations
7.
Little, Bertis B., et al.. (1993). Megadose carbamazepine during the period of neural tube closure. Obstetrics and Gynecology. 82(4, Part 2). 705–708. 1 indexed citations
8.
Satin, A. J., et al.. (1993). Chorioamnionitis: A harbinger of dystocia. International Journal of Gynecology & Obstetrics. 40(2). 188–188. 44 indexed citations
9.
Little, Bertis B., et al.. (1993). Megadose carbamazepine during the period of neural tube closure. Obstetrics and Gynecology. 82(4). 705–708. 6 indexed citations
10.
Andrews, William, Susan M. Ramin, Mark C. Maberry, et al.. (1992). Effect of Type of Anesthesia on Blood Loss at Elective Repeat Cesarean Section. American Journal of Perinatology. 9(3). 197–200. 28 indexed citations
11.
Maberry, Mark C., et al.. (1992). Antibiotic Concentration in Maternal Blood, Cord Blood and Placental Tissue in Women with Chorioamnionitis. Gynecologic and Obstetric Investigation. 33(3). 185–186. 12 indexed citations
12.
Maberry, Mark C., Richard Mason, F. Gary Cunningham, & Jack A. Pritchard. (1992). Pregnancy complicated by hereditary spherocytosis.. PubMed. 79(5 ( Pt 1)). 735–8. 6 indexed citations
13.
Bawdon, Roger E., et al.. (1991). Trimethoprim and Sulfamethoxazole Transfer in the in vitro Perfused Human Cotyledon. Gynecologic and Obstetric Investigation. 31(4). 240–242. 7 indexed citations
14.
Maberry, Mark C., et al.. (1991). Intrapartum Antibiotic Therapy for Suspected Intraamniotic Infection: Impact on the Fetus and Neonate. Clinical Obstetrics & Gynecology. 34(2). 345–351. 9 indexed citations
15.
Maberry, Mark C., et al.. (1991). Anaerobic Coverage for Intra-Amnionic Infection: Maternal and Perinatal Impact. American Journal of Perinatology. 8(5). 338–341. 17 indexed citations
16.
Maberry, Mark C., et al.. (1990). Alpha-Thalassemia: Prenatal Diagnosis and Neonatal Implications. American Journal of Perinatology. 7(4). 356–358. 5 indexed citations
17.
Milewich, Leon, Stephen J. Fortunato, Michael C. Barris, et al.. (1990). 17β-Hydroxysteroid oxidoreductase activity in human maternal and umbilical cord sera. Journal of Steroid Biochemistry. 35(1). 67–75. 9 indexed citations
18.
Wendel, George D., Mark C. Maberry, James T. Christmas, Matthew S. Goldberg, & Michael V. Norgard. (1990). Examination of amniotic fluid in diagnosing congenital syphilis with fetal death. International Journal of Gynecology & Obstetrics. 32(3). 297–298. 27 indexed citations
19.
Ramin, Susan M., Mark C. Maberry, & Larry C. Gilstrap. (1989). Congenital Heart Disease. Clinical Obstetrics & Gynecology. 32(1). 41–47. 6 indexed citations
20.
Bleasdale, John E., Mark C. Maberry, & J. Gerald Quirk. (1982). myo-Inositol homeostasis in foetal rabbit lung. Biochemical Journal. 206(1). 43–52. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026